Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 3, 1998, Pages 1113-1122

  Hardin, J Shane ^a   Wessinger, William D ^a   Proksch, Joel W ^a   Owens, S Michael ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXYLAMINE; DEXOXADROL; DIZOCILPINE; DRUG ANALOG; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; KETAMINE; METHAMPHETAMINE; MONOCLONAL ANTIBODY; PHENCYCLIDINE; PHENCYCLIDINE MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BRAIN TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTOXICATION; DRUG SYNTHESIS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC AGENTS; ANIMALS; CYCLOHEXYLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031808164     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chaudieu I, Vignon J, Chicheportiche M, Kamenka J-M, Trouiller G and Chicheportiche R (1989) Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs. Pharmacol Biochem Behav 32:699-705.
2. Cook CE, Brine DR, Jeffcoat AR, Hill JM, Wall ME, Perez-Reyes M and Di Guiseppi SR (1982a) Phencyclidine disposition after intravenous and oral doses. Clin Pharmacol Ther 31:625-634.
3. Cook CE, Brine DR, Quin GD, Perez-Reyes M and Di Guiseppi SR (1982b) Phencyclidine and phenylcyclohexene disposition after smoking phencyclidine. Clin Pharmacol Ther 31:635-641.
4. Goldenberg DM (1993) Monoclonal antibodies in cancer detection and therapy. Am J Med 94:297-312.
5. Heishman SJ, Stitzer ML, Bigelow GE and Liebson IA (1989) Acute opioid physical dependence in post-addict humans: Naloxone dose effects after brief morphine exposure. J Pharmacol Exp Ther 248:127-134.
6. Hickey AR, Wenger TL, Carpenter VP, Tilson HH, Hlatky MA, Furberg CD, Kirkpatrick CH, Strauss HC and Smith TW (1991) Digoxin Immune Fab therapy in the management of digitalis intoxication: Safety and efficacy results of an observational surveillance. J Am Coll Cardiol 17:590-598.
7. Hori T, Suzuki T, Baba A, Abe S, Yamamoto T, Moroji T and Shiraishi H (1996) Effects of phencyclidine metabolites on serotonin uptake in rat brain. Neurosci Lett 209:153-156.
8. Howlett TA and Rees LH (1986) Endogenous opioid peptides and hypothalamopituitary function. Ann Rev Physiol 48:527-536.
9. Jentsch JD, Redmond Jr DE, Elsworth JD, Taylor JR, Youngren KD and Roth RH (1997) Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (Wash DC) 277:953-955.
10. 3H]TCP binding: Effects of glycine, magnesium and N-methyl-D-aspartate agonists. Eur J Pharmacol 152:141-146.
11. Kirkpatrick CH (1991) Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. The Digibind Study Advisory Panel Am J Emerg Med 9:7-10.
12. Lodge D and Anis NA (1982) Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat. Eur J Pharmacol 77:203-204.
13. Maurice T, Vignon J, Kamenka J-M and Chicheportiche R (1991) Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J Neurochem 56:553-559.
14. McCarron MM, Schulze BW, Thompson GA, Conder MC and Goetz WA (1981a) Acute phencyclidine intoxication: Incidence of clinical findings in 1,000 cases. Ann Emerg Med 10:237-242.
15. McCarron MM, Schulze BW, Thompson GA, Conder MC and Goetz WA (1981b) Acute phencyclidine intoxication: Clinical patterns, complications, and treatment. Ann Emerg Med 10:290-297.
16. McClurkan MB, Valentine JL, Arnold L and Owens SM (1993) Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats. J Pharmacol Exp Ther 266:1439-1445.
17. Miller NS, Gold MS and Millman R (1988) PCP: A dangerous drug. Am Fam Physician 38:215-218.
18. Owens SM and Mayersohn M (1986) Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs. Drug Metab Dispos 14:52-58.
19. Owens SM, Zorbas M, Lattin DL, Gunnell M and Polk M (1988) Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor. J Pharmacol Exp Ther 246:472-478.
20. Rodbard D (1974) Statistical quality control and routine data processing for radio-immunoassays and immunoradiometric assays. Clin Chem 20:1255-1270.
21. Rosenbaum G, Cohen BD, Luby ED, Gottlieb JS and Yelen D (1959) Comparison of Sernyl with other drugs. Arch Gen Psych 1:651-656.
22. Sams-Dodd F (1995) Automation of the social interaction test by a video-tracking system: Behavioral effects of repeated phencyclidine treatment. J Neurosci Meth 59:157-167.
23. Sams-Dodd F (1996) Phencyclidine-induced stereotyped behavior and social isolation in rats: A possible animal model of schizophrenia. Behav Pharmacol 7:3-23.
24. Shannon HE (1981) Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat. J Pharmacol Exp Ther 216:543-551.
25. Valentine JL, Arnold LW and Owens SM (1994) Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther 269:1079-1085.
26. Valentine JL, Mayersohn M, Wessinger WD, Arnold L and Owens SM (1996) Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharmacol Exp Ther 278:709-716.
27. Valentine JL and Owens SM (1996) Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissue in rats. J Pharmacol Exp Ther 278:717-724.
28. 3H]TCP: A new tool with high affinity for the PCP receptor in rat brain. Brain Res 280:194-197.
29. 3H]BTCP): A new phencyclidine analog selective for the dopamine uptake complex. Eur J Pharmacol 148:427-436.
30. Vignon J, Vincent JP, Bidard JN, Kamenka J-M, Geneste P, Monier S and Lazdunski M (1982) Biochemical properties of the brain phencyclidine receptor. Eur J Pharmacol 81:531-542.
31. Walberg CB, McCarron MM and Schulze BW (1983) Quantification of phencyclidine in serum by enzyme immunoassay: Results in 405 patients. J Anal Toxicol 7:106-110.
32. 3H phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76:5372-5376.